Skip to main content
Sailong Pharmaceutical Group Co., Ltd. logo

Sailong Pharmaceutical Group Co., Ltd. — Investor Relations & Filings

Ticker · 002898 ISIN · CNE1000032S5 LEI · 8368004F5Y6BSB6US681 Shenzhen Stock Exchange Manufacturing
Filings indexed 1,116 across all filing types
Latest filing 2022-04-26 Interim / Quarterly Rep…
Country CN China
Listing Shenzhen Stock Exchange 002898

About Sailong Pharmaceutical Group Co., Ltd.

https://www.sailong.cn

Sailong Pharmaceutical Group Co., Ltd. is a pharmaceutical enterprise focused on the research, development, production, and marketing of high-end generic drugs and innovative formulations. The company maintains an integrated industrial chain encompassing active pharmaceutical ingredients (APIs) and finished dosage forms. Its product portfolio primarily targets therapeutic areas such as cardiovascular and cerebrovascular diseases, the digestive system, and anti-infective treatments. Key products include Monosialotetrahexosylganglioside Sodium Injection and Pantoprazole Sodium for Injection. The group emphasizes technological innovation and quality control to provide clinical solutions for complex medical conditions.

Recent filings

Filing Released Lang Actions
2022年一季度报告
Interim / Quarterly Report Classification · 98% confidence The document is titled '赛隆药业集团股份有限公司 2022 年第一季度报告全文' which translates to 'Sailong Pharmaceutical Group Co., Ltd. 2022 First Quarter Report Full Text'. It contains detailed financial data including balance sheets, profit and loss statements, cash flow statements, and shareholder information for the first quarter of 2022. The document explicitly states it is a quarterly report and includes comprehensive financial statements and analysis for a period shorter than a full fiscal year. It also mentions that the report is unaudited. This matches the definition of an Interim / Quarterly Report (IR). The document length is over 12,000 characters, indicating it is the full report, not just an announcement. Therefore, the correct classification is IR with high confidence. Q1 2022
2022-04-26 Chinese
年度募集资金使用鉴证报告
Audit Report / Information Classification · 95% confidence The document is a detailed verification report on the storage and use of raised funds by the company for the fiscal year 2021. It includes audit opinions from an accounting firm, references to regulatory guidelines on raised funds management, detailed tables of fund usage, and disclosures about the management and use of the raised capital. The document is titled as a "鉴证报告" (verification report) specifically about the "募集资金存放与使用情况" (raised funds storage and usage). It is not a full annual report or interim financial report but a specialized audit/verification report on a specific aspect of the company's financials related to capital raised from stock issuance. This fits the definition of an Audit Report / Information (AR) as it is a standalone audit/verification report on a specific financial aspect, not a full annual report or earnings release. The document length (8515 characters) and content confirm it is the report itself, not just an announcement or certification letter. Therefore, the correct classification is AR with high confidence. FY 2021
2022-04-26 Chinese
内部控制自我评价报告
Audit Report / Information Classification · 95% confidence The document is titled as an "Internal Control Self-Evaluation Report" for the year 2021 by a company. It discusses the company's internal control environment, risk assessment, control activities, information and communication, and internal control supervision. It includes detailed evaluation criteria for financial and non-financial internal control defects, and concludes on the effectiveness of internal controls without major deficiencies. The document is a comprehensive report on internal control evaluation, which aligns with the scope of an Audit Report / Information (AR) as it focuses on internal control assessment and related audit activities rather than a full annual report or other categories. The length (8464 characters) and detailed content confirm it is the report itself, not just an announcement or certification. Therefore, the appropriate classification is AR (Audit Report / Information). FY 2021
2022-04-26 Chinese
年度股东大会通知
AGM Information Classification · 100% confidence The document is a detailed notice about the convening of the 2021 Annual General Meeting (AGM) of the company 赛隆药业集团股份有限公司. It includes information about the meeting date, location, agenda items to be voted on, voting procedures (including online voting), and proxy authorization forms. The document does not contain the actual annual report, financial statements, or results of the meeting, but rather the notification and instructions for shareholders to participate in the AGM. This fits the definition of AGM Information (AGM-R), which covers presentations and materials shared during the AGM or notices about the AGM itself. The document length is over 5,000 characters and contains detailed meeting information, not just a brief announcement, so it is not a Report Publication Announcement (RPA). Therefore, the correct classification is AGM Information (AGM-R).
2022-04-26 Chinese
董事会决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the eighth meeting of the third board of directors of the company. It includes voting results on various agenda items such as approval of annual reports, financial reports, audit appointments, internal control reports, and amendments to company bylaws. The document repeatedly states that these resolutions will be submitted to the shareholders' meeting for approval. It also references multiple related announcements and reports published elsewhere (on cninfo.com.cn). The document is not the actual annual report, financial report, or audit report itself, but rather a formal announcement of board meeting decisions and approvals. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors or senior management. The document length (4791 characters) and content confirm it is not a brief report publication announcement or a full financial report. Therefore, the correct classification is MANG with high confidence.
2022-04-26 Chinese
2021年年度报告摘要
Annual Report Classification · 100% confidence The document is titled as "2021 年年度报告摘要" which translates to "2021 Annual Report Summary". It contains detailed financial data including main business description, product information, accounting data, financial indicators for the year 2021, quarterly financial data, shareholder information, and other comprehensive details typical of an annual report. The document length is substantial (13,879 characters), indicating it is not a brief announcement or a simple notice. It includes actual financial figures and analysis rather than just referencing or announcing a report. Therefore, this document fits the definition of an Annual Report (10-K). FY 2021
2022-04-26 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.